16 April 2019 - Deborah Wilkes
Premium
Johnson & Johnson's (J&J's) OTC business in the US reported sales up by almost a tenth during the first quarter of 2019, following market share gains for Tylenol analgesics and the acquisition of natural health specialist Zarbee's.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.